The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Maksimov A.Yu.

National Medical Oncology Research Center of Ministry of Health of the Russian Federation

Kostoev I.S.

National Medical Oncology Research Center of Ministry of Health of the Russian Federation

Demidova A.A.

Rostov State Medical University of Ministry of Health of the Russian Federation

Prohodnaya V.A.

Rostov State Medical University of Ministry of Health of the Russian Federation

Akinfiev V.M.

I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation

Differential bioinformational model for diagnostics of inflammatory and tumor diseases of the parotid salivary gland

Authors:

Maksimov A.Yu., Kostoev I.S., Demidova A.A., Prohodnaya V.A., Akinfiev V.M.

More about the authors

Journal: Stomatology. 2021;100(1): 24‑29

Read: 1312 times


To cite this article:

Maksimov AYu, Kostoev IS, Demidova AA, Prohodnaya VA, Akinfiev VM. Differential bioinformational model for diagnostics of inflammatory and tumor diseases of the parotid salivary gland. Stomatology. 2021;100(1):24‑29. (In Russ.)
https://doi.org/10.17116/stomat202110001124

Recommended articles:
The role of immuno-inflammatory factors in the deve­lopment of nega­tive symptoms in schi­zophrenia. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):42-48
Inflammatory aging. Part 1. The principal biochemical mechanisms. Russian Journal of Preventive Medi­cine. 2024;(12):145-150
Functional cyto­kine redu­ndancy in pregnancy. Russian Journal of Human Reproduction. 2024;(6):73-80
Biomarkers of athe­rothrombotic and cardioembolic subtypes of acute ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):20-26

References:

  1. Vajradyan VT, Mudunov AM, Savostikova MV. Modern assessment of the epigenetic status and effectiveness of chemotherapy for malignant tumors of the salivary glands. Vestnik RONC im. N.N. Blohina. 2015-2016;26(4-1):23-28. (In Russ.).
  2. Vander Poorten V, Hunt J, Bradley PJ, Haigentz M Jr, Rinaldo A, Mendenhall WM, Suarez C, Silver C, Takes RP, Ferlito A. Recent trends in the management of minor salivary gland carcinoma. Head Neck. 2014;36(3):444-455.  https://doi.org/10.1002/hed.23249
  3. Taghavi N, Sargolzaei S, Mashhadiabbas F, Akbarzadeh A, Kardouni P. Salivary gland tumors: a 15-year report from Iran. Turk Patoloji Derg. 2016;32(1):35-39.  https://doi.org/10.5146/tjpath.2015.01336
  4. Balkanov AS, Bychenkov OA, Sipkin AM, Gaganov LE. Combined treatment of cancer of the parotid salivary gland. Almanakh klinicheskoi medicini. 2017;45(4):309-313. (In Russ.). https://doi.org/10.18786/2072-0505-2017-45-4-309-313
  5. Runova MB. Modern principles of diagnosis and treatment of diseases of the salivary glands. Sovremennye tekhnologii v medicine. 2011;3:152-156. (In Russ.).
  6. Malyshev ME, Lobejko VV, Iordanishvili AK. Indicators of secretory immunity of saliva in patients with various diseases of the salivary glands. Kurskij nauchno-prakticheskij vestnik «Chelovek i ego zdorov’e». 2015;1:40-47. (In Russ.).
  7. Poorten VV, Meulemans J, Delaere P, Nuyts S, Clement P. Molecular Markers and Chemotherapy for Advanced Salivary Cancer. Curr Otorhinolaryngol Rep. 2014;2:85-96.  https://doi.org/10.1007/s40136-014-0040-2
  8. Kochurova EV, Kozlov SV, Nikolenko VN, Gujter OS. Diagnostic possibilities of oral fluid biomarkers for tumors of the parotid. Rossijskij onkologicheskij zhurnal. 2013;5:30-32. (In Russ.).
  9. Yoshimura A. Singal transduction of inflammatory cytokines and tumor development. Cancer Sci. 2006;97:439-447.  https://doi.org/10.1111/j.1349-7006.2006.00197.x
  10. Ishihara K, Hirano T. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine Growth Factor Rev. 2002;13:357-368.  https://doi.org/10.1016/s1359-6101(02)00027-8
  11. Adelstein DJ, Koyfman SA, El-Naggar AK, Hanna EY. Biology and management of salivary gland cancers. Semin Radiat Oncol. 2012;22(3):245-253.  https://doi.org/10.1016/j.semradonc.2012.03.009
  12. Nibali L, Fedele S, D’Aiuto F, Donos N. Interleukin-6 in oral diseases: a review. Oral Diseases. 2012;18(3):236-243.  https://doi.org/10.1111/j.1601-0825.2011.01867.x
  13. Selvam NP, Sadaksharam J. Salivary interleukin-6 in the detection of oral cancer and precancer. Asia Pac J Clin Oncol. 2015;11:236-241.  https://doi.org/10.1111/ajco.12330
  14. Lee SK, Kwon MS, Lee YS, et al. Prognostic value of expression of molecular markers in adenoid cystic cancer of the salivary glands compared with lymph node metastasis: a retrospective study. World J Surg Oncol. 2012;10:266.  https://doi.org/10.1186/1477-7819-10-266
  15. Andreasen S, Hamilton M, Morten T, Lennart G, et al. Activation of the interleukin—6/Janus kinase/STAT3 pathway in pleomorphic adenoma of the parotid gland. APMIS. 2015;123(8):706-715.  https://doi.org/10.1111/apm.12407
  16. Lagha A, Chraiet N, Ayadi M, et al. Systemic therapy in the management of metastatic or advanced salivary gland cancers. Oral Oncol. 2012;48(10):948-957.  https://doi.org/10.1186/1758-3284-4-19
  17. Dumoutier L, Renauld J. Viral and cellular interleukin-10 (IL-10)-related cytokines: from structures to functions. Eur Cytokine Netw. 2002;13:5-15. 
  18. Gurzu S, Krause M, Ember I. Mena, a new available marker in tumors of salivary glands? Eur J Histochem. 2012;56(1):e8.  https://doi.org/10.4081/ejh.2012.e8
  19. Ketlinskij SA. The role of T-helpers of types 1 and 2 in the regulation of cellular and humoral immunity. Immunologiya. 2002;23(2):77-79. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.